Australian TAVI activity consistent with international best practice

How to deliver ‘4 pillars’ of treatment in T2D and CKD

ACE-inhibitor fails to prevent heart damage during anthracycline chemotherapy

Why the pathology bulk-billing campaign is more about driving industry profits than saving you money

Pharma funding: which specialties accept the most payments?

Clopidogrel monotherapy preferable to DAPT prolongation after PCI


more news